Health Robotics Announces Termination of its Distribution Contract With McKesson Corporation in North America

By Health Robotics, PRNE
Sunday, February 27, 2011

BOZEN, Sud-Tirol, Italy, February 28, 2011 - Health Robotics today announced that earlier last week, it served proper
notice to McKesson of the immediate termination for cause of their exclusive
CytoCare distribution and services contract in North America, as well as the
termination for cause of their non-exclusive distribution agreement for
i.v.STATION and i.v.SOFT within a subset of McKesson Automation's customers.

Health Robotics does not expect this early termination to have a material
impact on its overall North American installations given the fact that
McKesson's contracts represented less than 10 % of all Health Robotics'
contracted installations in the USA and Canada since the companies executed
their initial IV Automation agreement in August 2009.

More specifically, i.v.STATION and i.v.SOFT customers should not be
disrupted at all by this termination due to the fact that 100% of these
installations were contracted for and implemented by non-McKesson Health
Robotics' partners and their associates, who will continue to support these
i.v.STATION and i.v.SOFT customers without pause.

Until further notice and pending regulatory compliance review, CytoCare
customers that have contracts with McKesson Automation should refer their
questions about ongoing maintenance and support to McKesson Corporation.
Additional non-McKesson CytoCare customers in North America may continue to
obtain support from other Health Robotics' channel partners, whose roles may
now be expanded as a result of the early termination of the McKesson
contract. Health Robotics is committed to quickly reviewing and revamping its
channel partner strategy for this complex sector in North America, as well as
reaching an agreement with McKesson for the continued support of its
customers.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing over 175 hospital
installations in 5 continents with robotics technology and software
automation solutions deployed utilizing virtual high-availability technology.
Its world-leading solutions CytoCare(R) [hazardous IVs], i.v.STATION(R)
[non-hazardous IVs], i.v.SOFT(R) [workflow engine for manual compounding],
MEDarchiver(R) [life-critical clinical information system], and
TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly
contribute to ease hospitals' growing pressures to improve patient safety,
increase throughput and contain costs. Through the effective and efficient
production of sterile, accurate, tamper-evident and ready-to-administer IVs,
Health Robotics' solutions help hospitals eliminate life-threatening drug and
diluent exchange errors, decrease other medical mistakes and sterility risks,
work more efficiently, reduce waste and controlled substances' diversion, and
diminish the gap between rising patient volume/acuity and scarce medical,
nursing, and pharmacy staff. For more information, please visit:
www.health-robotics.com

    For additional information, please contact:

    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372

For additional information, please contact: Claudia Flaim, Marketing Coordinator, flaim at health-robotics.com, Phone: +39-0471-200-372

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :